Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:12 AM
Ignite Modification Date:
2025-12-25 @ 4:12 AM
NCT ID:
NCT05827120
Eligibility Criteria:
Inclusion Criteria:
* first episode of acute iliofemoral DVT
* duration of symptoms \<14 days
* symptomatic patients with no or limited response to initial anticoagulation therapy in terms of symptomatology and signs of recanalization
* low bleeding risk
* good functional capacity and life expectancy
Exclusion Criteria:
* \- presence of malignity (2 centers out of 3)
* pregnancy
* haemorrhagic diathesis / high risk of bleeding
* negative prognosis of survival
* renal / hepatic failure
* chronic course of DVT
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT05827120
Study Brief:
Protocol Section:
NCT05827120